WORLD’S LARGEST STUDY IN INTRAVENOUS CATHETER SECUREMENT FOR CHILDREN AND CATHETER FAILURE REDUCTION
Brooke Charters, Paediatric Emergency Nurse
Gold Coast Hospital and Health Service
PEOPLE IN HEALTH CARE
Filmed in Southport, Queensland | December 2024
Brooke Charters is a dynamic Paediatric Emergency Nurse who works at the Gold Coast University Hospital in Queensland.
After leaving school unsure of her career path, she ventured into disability support, which sparked her interest in nursing. She pursued a Bachelor of Nursing at Southern Cross University, and during her placement in Africa, she discovered her passion for paediatrics instead of mental health nursing.
Since completing her post grad certificate in paediatric acute care and a passion ignited from working frontline in the Paediatric Emergency, Brooke has developed a wide variety of clinical research interests, especially in cannulation, children’s mental health trauma and pain management.
An opportunity arose when she was approached for research ideas related to securing cannulas, a frequent issue in paediatric care.
Brooke was the first nurse to become a Principal Investigator on an Emergency Medicine Foundation (EMF) Queensland Research Program grant when it was opened to nurses. Having seen first-hand how one in four cannulas used in treating children were failing
and needed to be reinserted Brooke looked for an opportunity to find a solution.
The study enrolled children aged six months to eight years, aiming to save cannulas and reduce reinsertion trauma. Her study’s findings showed significant improvements in securing cannulas, highlighting a potential solution to a common problem.
Brooke initiated a study with a randomised control trial (RCT) comparing standard care to an integrated dressing with tissue adhesive.
Brooke’s research became the world’s largest study of its kind and in May 2024 the results of the study were published in JAMA Pediatrics. Her mission is to drive change and enhance the hospital experience for children globally.
-
WA and QLD RSV Immunisation programs show drops in infant hospitalisations
RSV is the number one cause of hospitalisation of Australian children under five years of age, according to the Immunisation Foundation of Australia (IFA). There are mounting concerns that Australians at greatest risk of severe Respiratory Syncytial Virus, or RSV will miss out on protection against the lung infection, with the Federal Government failing to commit to a national RSV immunisation program.
-
Redefining diversity in clinical trials
Ensuring inclusion, diversity, equity and patient input in the development of novel drugs and medical devices has become well accepted in health care. However appropriate implementation of these elements has been a challenge for many. Only by implementing these conscious inputs can patient outcomes be improved and health disparities in marginalised groups be addressed.
Australian Health Journal spoke to Gillian Mason, Consumer and Community Involvement Lead at Hunter Medical Research Institute in Newcastle, NSW on this topic discussed at the recent ARCS Conference in Sydney.
-
Elevating Professional Standards in the Medtech and Pharmaceutical Sector
ARCS Australia Ltd, the peak body representing professionals in the MedTech and Pharmaceutical sector, this week announced a series of significant changes at its annual conference.
Dr Tim Boyle, CEO of ARCS Australia Ltd speaking to Australian Health Journal says, “These initiatives are central to strategy to build professionalism within the sector, increase capability and enhance the professional standing of its members.”
